Biotechnology

Daewoong Pharmaceutical Acquires Halal Certification for 'Easyef' through Daewoong Infion

SEOUL, South Korea and JAKARTA, Indonesia, May 27, 2020 /PRNewswire/ -- Daewoong Pharmaceutical (CEOSengho Jeon) announced on May 25 that the Indonesian joint venture Daewoong Infion (CEOChang Woo Suh) obtained Halal certification for the diabetic foot ulcer drug 'Easyef topical solution(Easyef)...

2020-05-27 10:00 4542

Innovent Announces First Patient Dosed in A Phase 1 Clinical Trial of Anti-TIGIT Monoclonal Antibody in China

SUZHOU, China, May 26, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today anno...

2020-05-26 07:30 9565

HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China

SINGAPORE, May 25, 2020 /PRNewswire/ -- Singapore medtech company HistoIndex 's AI-based stain-free digital pathology platform has long been established as a suitable tool for global clinical guidelines that outline the assessment, prevention and treatment of Chronic ...

2020-05-25 06:00 3508

Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)

SEATTLE, May 21, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, has announced its partnership withTakara Bio.The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine, wit...

2020-05-21 14:00 3739

Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions

SOMERSET, N.J., May 21, 2020 /PRNewswire/ -- Catalent (NYSE:CTLT), a global leader in clinical supply services, today announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda Pharmaceuticals, Nagoya Aichi, Japan. This purcha...

2020-05-21 12:00 14466

VeChain and I-Dante Co-developed E-HCert, A Blockchain-based COVID-19 Records App For the Citizens of Cyprus

SHANGHAI, May 20, 2020 /PRNewswire/ -- With the pandemic putting healthcare systems under strain worldwide, Electronic Health Record (EHR) systems are also shifting requirements for data security and sharing. As the leading public blockchain platform, VeChain furthers the collaboration with I-Dan...

2020-05-20 23:00 6596

QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development

NEWARK, Delaware, May 19, 2020 /PRNewswire/ -- QPS, a global contract research organization (CRO) that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics. QPS announces an expanded and up...

2020-05-19 18:55 3168

Invivoscribe Announces FDA Approval for Distribution of the LeukoStrat CDx FLT3 Mutation Assay as an IVD Kit in the United States

SAN DIEGO, May 19, 2020 /PRNewswire/ -- Invivoscribe to offer the LeukoStrat® CDxFLT3 Mutation Assay as an FDA approved kit with analysis software. In 2017, Invivoscribe's LeukoStrat® CDx FLT3 Mutation Assay became the first FDA approvedFLT3 test and launched as a testing service at LabPMM, Invi...

2020-05-19 18:00 3012

Excelra to Provide Lawrence Livermore National Laboratory With Small Molecule Medicinal Chemistry Intelligence Data to Help Develop Drug Design Platform

HYDERABAD, India, May 19, 2020 /PRNewswire/ -- Under a three-year agreement, Excelra  – a leading global data and analytics company – will provide Lawrence Livermore National Laboratory (LLNL) withGOSTAR , a small molecule medical chemis...

2020-05-19 10:00 3019

Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic

* Exyte offers the new ExyCell® modular technology for fast-track construction of biologicals production facilities compliant with the current good manufacturing practice (cGMP). * Univercells Technologies delivers the integrated NevoLine™ biomanufacturing platform, including scale-X™ bioreac...

2020-05-19 08:15 4792

WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States

SHANGHAI and WORCESTER, Mass., May 19, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and the Worcester Business Development Corporation (WBDC) announced today the successful signing of a land deal for WuXi Bio...

2020-05-19 08:00 2954

Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen

* As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficac...

2020-05-15 11:52 7536

AGC Biologics to Participate in First-Ever BIO Digital Conference

SEATTLE, May 14, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), will be participating in the first-ever BIO Digital event. BIO International Conference is holding its annual event virtually this year in order to safely co...

2020-05-14 20:30 3761

Halodine(R) Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19)

FORT LAUDERDALE, Florida, May 14, 2020 /PRNewswire/ -- Veloce BioPharma LLC reports today that their Halodine® Antiseptics have demonstrated rapid viricidal efficacy against SARS-CoV-2, the virus that causes COVID-19. Halodine® is a proprietary povidone-iodine antiseptic developed in partnership ...

2020-05-14 09:26 3422

Dreamwood(TM) Offers Olfactive Warmth, Cosmetic Benefits and Positive Impact

GENEVA, May 13, 2020 /PRNewswire/ -- Firmenich, the world's largest privately-owned perfume and taste company, is proud to launch its newest exclusive, captive ingredient Dreamwood™. Inspired by the iconic Mysore sandalwood, Dreamwood™ offers the signature mystical, creamy olfactive warmth with ...

2020-05-13 21:53 2665

CMAB Biopharma's development and manufacturing platform successfully completes Q-1802 bispecific antibody project for QureBio within 9 months

* CMAB completed a full scope development and manufacturing project for Q-1802 in 9 months for dual IND filing inChina and the US * Completion of the project demonstrates the significant speed to clinic achievable with CMAB's fully integrated development and manufacturing platform * QureBio'...

2020-05-13 18:29 2692

Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment

MUMBAI, India, May 13, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (and hereafter referred to as "Cipla") today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine R...

2020-05-13 17:51 3623

Hummingbird Bioscience Closes US$25 Million Investment With Series B Extension

SINGAPORE, May 11, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company focused on the discovery and development of new breakthrough therapies, has closed an extended Series B funding round ofUS$25 million. This brings the total capital raised through financing activ...

2020-05-11 08:00 1692

Sai Life Sciences Joins the Global 'COVID Moonshot' Project

HYDERABAD, India, May 7, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growingContract Development & Manufacturing Organizations (CDMOs) , today announced its collaboration...

2020-05-07 09:00 4166

Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

SUZHOU, China, May 6, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, today jointly...

2020-05-07 07:30 10732
1 ... 172173174175176177178 ... 181

Week's Top Stories